Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 5/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | NQO2 | P16083 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.41 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 2/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.40 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.40 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.40 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5736824 | 0.98 | EGFR (0.46) | EGFRCYP1A2CYP3A4HSD17B10ALDH1A1 | |
| Formic Acid SCHEMBL30699784 | 0.89 | EGFR (0.41) | EGFRCYP1A2CYP3A4HSD17B10ALDH1A1 | |
| SCHEMBL29832602 | 0.82 | KDM1A (0.46) | EGFRCYP1A2CYP3A4ALDH1A1LMNA | |
| SCHEMBL5682821 | 0.81 | MCHR1 (0.41) | EGFRGRM5HTR1AHTR1DHTR1B | |
| SCHEMBL27647885 | 0.76 | HTR1A (0.44) | EGFRHTR1AHTR1DHTR1B | |
| SCHEMBL1770673 | 0.75 | ALDH1A1 (0.35) | EGFRCYP1A2CYP3A4HSD17B10ALDH1A1 | |
| 1,2-Dimethoxybenzene SCHEMBL28232593 | 0.75 | EGFR (0.69) | EGFRCYP1A2CYP3A4HSD17B10ALDH1A1 | |
| SCHEMBL3820499 | 0.75 | EGFR (0.47) | EGFRCYP1A2CYP3A4ALDH1A1CYP2D6 | |
| SCHEMBL29096082 | 0.75 | SYK (0.57) | HSD17B10ALDH1A1LMNAGRM5KCNH2 | |
| SCHEMBL96953 | 0.75 | SYK (0.57) | HSD17B10ALDH1A1LMNAGRM5KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11407719-B2 | Anti-inflammatory agents | RESVERLOGIX CORP. (CA) | 2022-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11407719-B2 | Anti-inflammatory agents | VCAM1, ICAM1, IL6 | EGFR 3489/4885CYP1A2 3571/4885CYP3A4 3575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.